Enhancing tissue engineering and regenerative medicine product commercialization: the role of science in regulatory decision-making for the TE/RM product development

Timothy A. Bertram, Peter C. Johnson, Bill J. Tawil, Mark Van Dyke, Kiki B. Hellman

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Abstract

TERMIS-AM Industry Committee (TERMIS-AM/IC), in collaboration with the TERMIS-Europe (EU)/IC, conducted a symposium involving the European Medicines Agency and the U.S. Food and Drug Administration (FDA) toward building an understanding of the rational basis for regulatory decision-making and providing a framework for decisions made during the evaluation of safety and efficacy of TE/RM technologies. This symposium was held in August 2012 during the TERMIS-WC in Vienna, Austria. Emerging from this international initiative by the European Union and the United States, representatives from the respective agencies demonstrated that there are ongoing interagency efforts for developing common national practices toward harmonization of regulatory requirements for the TE/RM products. To extend a broad-based understanding of the role of science in regulatory decision-making, TERMIS-AM/IC, in cooperation with the FDA, organized a symposium at the 2014 TERMIS-AM Annual Meeting, which was held in Washington, DC. This event provided insights from leaders in the FDA and TERMIS on the current status of regulatory approaches for the approved TE/RM products, the use of science in making regulatory decisions, and TE/RM technologies that are in the development pipeline to address unmet medical needs. A far-ranging discussion with FDA representatives, industrialists, physicians, regenerative medicine biologists, and tissue engineers considered the gaps in today's scientific and regulatory understanding of TE/RM technologies. The identified gaps represent significant opportunities to advance TE/RM technologies toward commercialization.

Original languageEnglish (US)
Pages (from-to)2476-2479
Number of pages4
JournalTissue Engineering - Part A
Volume21
Issue number19-20
DOIs
StatePublished - Oct 1 2015
Externally publishedYes

ASJC Scopus subject areas

  • Bioengineering
  • Biochemistry
  • Biomaterials
  • Biomedical Engineering

Fingerprint

Dive into the research topics of 'Enhancing tissue engineering and regenerative medicine product commercialization: the role of science in regulatory decision-making for the TE/RM product development'. Together they form a unique fingerprint.

Cite this